Drug Type siRNA |
Synonyms Targeting KRAS G12V siRNA (Pramomolecular) |
Target |
Action inhibitors |
Mechanism KRAS G12V inhibitors(GTPase KRas G12V inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | Germany | 08 Jun 2024 | |
| Non-Small Cell Lung Cancer | Preclinical | Germany | 08 Jun 2024 | |
| Pancreatic Ductal Adenocarcinoma | Preclinical | Germany | 08 Jun 2024 |





